Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Addex Therapeutics Ltd./ 6-K

SEC Filing · 6-K

Addex Therapeutics Ltd.

SEC Filing

Filed Aug 26, 2026Accepted Aug 26, 2026, 6:05 AM EDTCIK 1574232Accession 0001171843-26-005744
View company →Permanent SEC source ↗
Share

Company context

Current securities

ADXNNASDAQ · ADR · Current

Recent company filings

  1. 6-K filingSep 25, 2026
  2. 4 filingSep 4, 2026
  3. 4 filingSep 4, 2026
  4. 4 filingSep 4, 2026
  5. 4 filingSep 4, 2026

As-filed source

Primary evidence
As filedOpen full document ↗